Atrium Therapeutics Inc (RNA)
Atrium Therapeutics Inc (RNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 860 | 12,475 | 3,847 | 1,573 | 2,973 |
| Gross Profit | 860 | 12,475 | 3,847 | 1,573 | 2,973 |
| Operating Expenses | 88,742 | 46,333 | 36,864 | 33,600 | 28,338 |
| Operating Income | -87,882 | -33,858 | -33,017 | -32,027 | -25,365 |
| Other Income | -149,219 | -140,584 | -124,298 | -83,746 | -76,891 |
| Pre-tax Income | -237,101 | -174,442 | -157,315 | -115,773 | -102,256 |
| Net Income Continuous | -237,101 | -174,442 | -157,315 | -115,773 | -102,256 |
| Net Income | $-237,101 | $-174,442 | $-157,315 | $-115,773 | $-102,256 |
| EBITDA(a) | $-87,882 | $-33,858 | $-33,017 | $-32,027 | $-25,365 |